We are live on ! Find out more
YMAB

Y-mAbs Therapeutics
YMAB

Delisted

YMAB was delisted on the 15th of September, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of YMAB yet.

YMAB Hedge Fund Activity: Q4 2025 in Review

0 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Y-mAbs Therapeutics (YMAB) for Q4 2025, worth a combined $0 — down 100% from $78.3K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of YMAB and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Brooklyn Investment Group, exiting entirely with an estimated $75.5K sold.

  • 0 institutional investors held Y-mAbs Therapeutics (YMAB) as of Q4 2025, down from 2 in Q3 2025.
  • Funds reported $0 of Y-mAbs Therapeutics stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Y-mAbs Therapeutics positions in Q4 2025 and 2 closed out, a net change of -2 holders.
  • The largest Y-mAbs Therapeutics seller in Q4 2025 was Brooklyn Investment Group, an estimated $75.5K sold.

Based on aggregated 13F filings for Q4 2025.